Real World Study to Describe the Effectiveness and Safety of Teprotumumab Among Thyroid Eye Disease Patients

Clinical trial NCT07085117 · COMPLETED

Trial details

NCT number: NCT07085117
Sponsor: Amgen
Status: COMPLETED
Study type: OBSERVATIONAL

Thyroid Eye Disease

Start date: 2025-07-02
Primary completion: 2025-08-10
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.